Cite
MLA Citation
Matthew Taylor et al.. “Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032.” Journal for immunotherapy of cancer, vol. 3, no. 2, 2015, pp. 1–2. http://access.bl.uk/ark:/81055/vdc_100080441580.0x0003f9